questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the National Institute for Health and Care Excellence's changes to drug appraisal methods on access to new treatments for people with secondary breast cancer.
answerText: The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended ...
heading: Breast Cancer: Medical Treatments